bland embolization

DEVICE2 trials

Sponsors

Abramson Cancer Center at Penn Medicine

Conditions

Liver MetastasesNeuroendocrine Tumor, MalignantRenal Cell CarcinomaRenal Cell Carcinoma Stage IV

Phase 1

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

TerminatedNCT04429321

Abramson Cancer Center at Penn MedicineRenal Cell Carcinoma, Renal Cell Carcinoma Stage IV

Start: 2020-08-26End: 2024-01-31Updated: 2024-04-26

Phase 2

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver

CompletedNCT02724540

Abramson Cancer Center at Penn MedicineLiver Metastases, Neuroendocrine Tumor, Malignant

Start: 2016-03-31End: 2024-11-08Updated: 2025-01-06

Related Papers

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial

Trials2018-07-1735 citations